about
Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cellsEctopic PDX-1 expression directly reprograms human keratinocytes along pancreatic insulin-producing cells fateChallenges to the clinical application of pluripotent stem cells: towards genomic and functional stabilityBiomedical and clinical promises of human pluripotent stem cells for neurological disordersChoice of Cell Source in Cell-Based Therapies for Retinal Damage due to Age-Related Macular Degeneration: A ReviewCell-based therapy for neural disorders--anticipating challengesMuse cells and induced pluripotent stem cell: implication of the elite modelUse of autologous blood-derived endothelial progenitor cells at point-of-care to protect against implant thrombosis in a large animal modelCellular treatments for spinal cord injury: the time is right for clinical trialsNeural stem cells: brain building blocks and beyondInduced Pluripotent Stem Cell as a New Source for Cancer ImmunotherapyThe Application of Human iPSCs in Neurological Diseases: From Bench to BedsideReport from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell ReplacementStem cell technology for tendon regeneration: current status, challenges, and future research directionsAn Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCsCanine Pluripotent Stem Cells: Are They Ready for Clinical Applications?Induced Pluripotent Stem Cells and Periodontal RegenerationThe immune response of stem cells in subretinal transplantationStem Cells and Progenitor Cells for Tissue-Engineered Solutions to Congenital Heart DefectsStem Cells and Regenerative Medicine: Myth or Reality of the 21th CenturyConcise Review: Methods and Cell Types Used to Generate Down Syndrome Induced Pluripotent Stem CellsPatient-Specific iPSC-Derived RPE for Modeling of Retinal DiseasesThe Dark Side of the Force - Constraints and Complications of Cell Therapies for StrokeSetting Up a Haplobank: Issues and SolutionsCardiac regeneration therapy: connections to cardiac physiologyPluripotent stem cells: immune to the immune system?Clinical implications of basic science discoveries: induced pluripotent stem cell therapy in transplantation--a potential role for immunologic toleranceStem cells in retinal regeneration: past, present and futureInduced pluripotent stem cell-derived cardiomyocytes for cardiovascular disease modeling and drug screeningNeurological disorders and the potential role for stem cells as a therapyImmunogenicity and tumorigenicity of pluripotent stem cells and their derivatives: genetic and epigenetic perspectivesThe potential for immunogenicity of autologous induced pluripotent stem cell-derived therapiesA poor imitation of a natural process: a call to reconsider the iPSC engineering techniqueConcise review: making and using clinically compliant pluripotent stem cell linesStem cell imaging: from bench to bedsideCurrent status of induced pluripotent stem cells in cardiac tissue regeneration and engineeringConsiderations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytesInduced pluripotent stem cells as a disease modeling and drug screening platformStem cell transplantation for motor neuron disease: current approaches and future perspectivesNew opportunities: harnessing induced pluripotency for discovery in diabetes and metabolism
P2860
Q21134034-A7AF65CB-7C1D-4929-90DD-99DB63802700Q21134993-05675602-7FCE-4020-8EEC-0597D3884278Q21183968-D7F9B255-782D-4886-B125-AFC369ABE890Q21284798-9F794973-D68A-4FA0-A372-0FC55199C34BQ21284849-2047C5EC-512B-418F-A097-5FF52B7190A3Q24615515-B320FA35-7FBF-4380-A852-CEF2524B2145Q24625690-4B06586C-1622-4E02-B0C0-67E48FF02793Q24628776-5C8B65CB-6635-4A3F-AF88-EAEC9349E668Q24630772-9A9FF6F4-AF87-482F-89BA-72B209878DA0Q24631889-B0E0D637-D96E-4E15-BF1C-932D56DFD10EQ26750579-7919988E-4417-4CA2-9967-5FA558523EFDQ26765876-45BBE817-71DF-4160-91B4-A03CC835EAD0Q26769878-85DE49C0-D34C-4D56-9891-084F5EA00F5CQ26771642-8E6CFB6C-B953-4A41-AB3B-B208EE68D1C9Q26775122-D6A48514-61EF-4074-9EE8-8D31590F0306Q26776075-3E86CC69-0AB5-4474-9A0D-3D3D14DF68B4Q26777488-34F438D0-E2C8-4B0F-BFF8-DB512B7FD33CQ26781292-EB851289-CB20-4877-9447-C067FB06B63BQ26785527-08A781B9-2FF4-488E-BF4F-35AF1C05E314Q26795447-AD940F43-ACD4-45D3-852A-30F91044DD90Q26799570-45094076-8CDE-4488-B4E8-D4BB3420D043Q26799586-FEAA98BA-6B6C-4DBB-A31E-C6816915B3BAQ26800181-C2F02E5B-C520-4F58-9E4A-000D248AD1DBQ26801583-9622FBA2-C69F-444F-8733-1A0ED8C5C2C3Q26822619-7C9ADC38-ADA9-4CF0-816B-70382D876242Q26823255-C75CF8DF-E904-4F94-BA4C-5D96ACCA467DQ26824632-B1B54098-9E1D-4BAC-A40D-CAF6BF6B029CQ26828014-FEB6AD2C-875D-4438-8380-FA2E9B901815Q26828408-C26B3EF5-888B-499B-894C-811D4D3B678DQ26830211-E881076D-461D-453F-8770-376816537B23Q26849530-081423B0-117E-435F-9E3C-48E7D33E3F8FQ26851666-C528732A-53CD-4F18-AB2A-16B3B519A0C5Q26851933-181FED9C-A537-4A8D-9233-36EEEA4B1FC1Q26852128-F5B7D9CD-EB90-454F-B433-CC9703A60548Q26861615-626BB84B-CC19-4358-B807-713D08601029Q26863381-6F779B42-6E1F-429E-B68C-FC56EC00416DQ26865173-87979C5A-DEB5-4DA8-945A-D2ECC1B5974DQ26865689-941D3AB7-D797-4828-9532-51207FFFC3C5Q26995278-B5A37ADC-5E33-4030-8670-8E8000D63FBBQ26995562-2481FC37-87F8-40E2-9D48-1C48871E85F4
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Immunogenicity of induced pluripotent stem cells
@ast
Immunogenicity of induced pluripotent stem cells
@en
type
label
Immunogenicity of induced pluripotent stem cells
@ast
Immunogenicity of induced pluripotent stem cells
@en
prefLabel
Immunogenicity of induced pluripotent stem cells
@ast
Immunogenicity of induced pluripotent stem cells
@en
P2093
P2860
P3181
P356
P1433
P1476
Immunogenicity of induced pluripotent stem cells
@en
P2093
P2860
P2888
P3181
P356
10.1038/NATURE10135
P407
P577
2011-05-13T00:00:00Z
P5875
P6179
1024326341